Successful delivery in a patient with clinically amyopathic dermatomyositis during pregnancy despite first-trimester acute exacerbation of interstitial lung disease

References

• Nossent HC, Swaak TJ. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J Rheumatol. 1990;17(6):771–6.
   PubMed Web of Science ®Google Scholar
• Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 1991;34(12):1538–45.
   PubMedGoogle Scholar
• Stojan G, Baer AN. Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management. Expert Rev Clin Immunol. 2012;8(5):439–53.
   PubMed Web of Science ®Google Scholar
• Iago PF, Albert SO, Andreu FC, Xavier MG, Jose RP, Jordi PL, Miquel VT. “Pregnancy in adult-onset idiopathic inflammatory myopathy”: Report from a cohort of myositis patients from a single center. Semin Arthritis Rheum. 2014.
   Web of Science ®Google Scholar
• Okada R, Miyabe YS, Kasai S, Hashimoto K, Yamauchi S, Yoshikawa M, et al. Successful treatment of interstitial pneumonia and pneumomediastinum associated with polymyositis during pregnancy with a combination of cyclophosphamide and tacrolimus. Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(3):142–8.
   PubMedGoogle Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.
   PubMed Web of Science ®Google Scholar
• Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol. 2004;14(6):425–34.
   PubMedGoogle Scholar
• Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52(5):1571–6.
   PubMed Web of Science ®Google Scholar
• Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T. Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology (Oxford). 2010;49(9):1726–33.
   PubMed Web of Science ®Google Scholar
• Gono T, Kawaguchi Y, Hara M, Masuda I, Katsumata Y, Shinozaki M, et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010;49(7):1354–60.
   PubMed Web of Science ®Google Scholar
• Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol. 2007;26(10):1647–54.
   PubMed Web of Science ®Google Scholar
• Hirakata M, Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2000;12(6):501–8.
   PubMed Web of Science ®Google Scholar
• Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum. 1992;35(4):449–56.
   PubMedGoogle Scholar
• Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum. 1983;26(5):604–11.
   PubMedGoogle Scholar
• Mathews MB, Reichlin M, Hughes GR, Bernstein RM. Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med. 1984;160(2):420–34.
   PubMed Web of Science ®Google Scholar
• Bunn CC, Bernstein RM, Mathews MB. Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. J Exp Med. 1986;163(5):1281–91.
   PubMed Web of Science ®Google Scholar
• Targoff IN. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol. 1990;144(5):1737–43.
   PubMed Web of Science ®Google Scholar
• Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999;162(4):2315–20.
   PubMed Web of Science ®Google Scholar
• Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology (Oxford). 2007;46(6):1005–8.
   PubMed Web of Science ®Google Scholar
• Hirakata M. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions (in Japanese). Nihon Rinsho Meneki Gakkai Kaishi. 2007;30(6):444–54.
   PubMedGoogle Scholar
• Targoff IN. Autoantibodies in polymyositis. Rheum Dis Clin North Am. 1992;18(2):455–82.
   PubMed Web of Science ®Google Scholar
• Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One. 2013;8(4):e60442. doi:10.1371/journal.pone.0060442.
   PubMed Web of Science ®Google Scholar
• Morihara K, Katoh N, Hirano S, Kishimoto S. Amyopathic dermatomyositis presenting during pregnancy. J Am Acad Dermatol. 2004;51(5):838–40.
   PubMed Web of Science ®Google Scholar
• Yassaee M, Kovarik CL, Werth VP. Pregnancy-associated dermatomyositis. Arch Dermatol. 2009;145(8):952–3.
   PubMedGoogle Scholar
• Lee SI, Yoo WH. Postpartum-onset dermatomyositis: case report and literature review. Mod Rheumatol. 2002;12(4):362–5.
   PubMedGoogle Scholar
• Kanoh H, Izumi T, Seishima M, Nojiri M, Ichiki Y, Kitajima Y. A case of dermatomyositis that developed after delivery: the involvement of pregnancy in the induction of dermatomyositis. Br J Dermatol. 1999;141(5):897–900.
   PubMed Web of Science ®Google Scholar
• Linardaki G, Cherouvim E, Goni G, Boki KA. Intravenous immunoglobulin treatment for pregnancy-associated dermatomyositis. Rheumatol Int. 2011;31(1):113–5.
   PubMed Web of Science ®Google Scholar
• Mosca M, Strigini F, Carmignani A, D'ascanio A, Genazzani AR, Bombardieri S. Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy. Arthritis Rheum. 2005;53(1):119–21.
   PubMedGoogle Scholar
• Williams L, Chang PY, Park E, Gorson KC, Bayer-Zwirello L. Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy. Obstet Gynecol. 2007; 109(2 Pt2):561–3.
   PubMed Web of Science ®Google Scholar
• Park IW, Suh YJ, Han JH, Shin YS, Choi JH, Park HS, Suh CH. Dermatomyositis developing in the first trimester of pregnancy. Korean J Intern Med. 2003;18(3):196–8.
   PubMedGoogle Scholar
• Tojyo K, Sekijima Y, Hattori T, Tsuyuzaki J, Nakamura A, Kita N, et al. A patient who developed dermatomyositis during the 1st trimester of gestation and improved after abortion (in Japanese). Rinsho Shinkeigaku. 2001;41(9):635–8.
   PubMedGoogle Scholar
• Papapetropoulos T, Kanellakopoulou N, Tsibri E, Paschalis C. Polymyositis and pregnancy: report of a case with three pregnancies. J Neurol Neurosurg Psychiatry. 1998;64(3):406.
   PubMed Web of Science ®Google Scholar
• Silva CA, Sultan SM, Isenberg DA. Pregnancy outcome in adult-onset idiopathic inflammatory myopathy. Rheumatology (Oxford). 2003;42(10):1168–72.
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit A, Ben-Chetrit E. Systemic lupus erythematosus induced by ovulation induction treatment. Arthritis Rheum. 1994;37(11):1614–7.
   PubMedGoogle Scholar